Table 4

Subgroup analysis by case severity for five most commonly studied clinical manifestations

ManifestationOutpatientsMixed non-severeNon-severe inpatientsSevere non-ITUIncludes ITU
StudiesPrevalence (95% CI)I2 StudiesPrevalence (95% CI)I2 StudiesPrevalence (95% CI)I2 StudiesPrevalence (95% CI)I2 StudiesPrevalence (95% CI)I2
Headache1444.0 (32.8 to 55.8)96.72041.9 (30.9 to 53.7)99.1128.9 (3.5 to 20.8)97.91612.1 (7.9 to 17.9)94.31910.8 (7.1 to 16.2)96.7
Myalgia1446.7 (36.8 to 56.8)95.71940.9 (28.2 to 55.0)99.399.9 (3.6 to 24.4)98.61311.3 (6.2 to 19.5)97.01920.4 (14.7 to 27.6)97.9
Anosmia1751.7 (42.2 to 61.1)97.12251.2 (40.8 to 61.4)98.2824.1 (8.2 to 53.1)98.0835.9 (10.4 to 73.0)99.0622.3 (11.0 to 40.1)95.2
Dysgeusia1745.2 (34.1 to 56.8)98.01450.2 (37.9 to 62.4)98.3621.6 (10.6 to 39.2)95.3725.3 (10.5 to 49.5)97.9617.3 (7.8 to 33.8)94.8
Fatigue1055.1 (43.3 to 66.3)97.81342.2 (29.3 to 56.3)98.11030.7 (16.7 to 49.4)98.01624.0 (15.9 to 34.4)97.31544.3 (31.5 to 58.0)99.1
  • ITU, intensive therapy unit.